Core Viewpoint - China Resources Medical (01515) has seen a slight increase in stock price, closing at 3.24 RMB, reflecting a 0.31% rise from the previous trading day. The company has disclosed further details regarding its health management service framework agreement, which involves significant projected coverage of employees and pricing structures for health check services [1]. Group 1: Stock Performance - As of December 18, 2025, the stock closed at 3.24 RMB, up 0.31% from the previous day [1] - The stock opened at 3.23 RMB, with a daily high of 3.25 RMB and a low of 3.21 RMB, achieving a transaction volume of 5.7015 million RMB [1] - The stock's 52-week high and low are 4.63 RMB and 3.18 RMB, respectively [1] Group 2: Health Management Service Framework Agreement - The company has released a supplementary announcement regarding the health management service framework agreement, detailing the annual transaction limits for the years 2025 to 2027, which are projected to cover approximately 20,000, 80,000, and 130,000 employees respectively [1] - The price per health check is estimated to range from 500 to 3,000 RMB, with buffer percentages of 34%, 13%, and 16% reserved for each year to accommodate business fluctuations [1] - Historical transaction amounts up to October 31, 2025, totaled approximately 2.28 million RMB, which does not fully reflect the seasonal demand for health checks at year-end [1] - The agreement was officially signed on December 4, 2025, with a retroactive service period starting from December 1, 2025, to enhance accounting and operational efficiency [1] - The applicable percentage rates for the related transactions are confirmed to be below 0.1%, and the annual limits are reiterated as fair and reasonable [1]
华润医疗（01515.HK）披露补充公告持续关连交易健康管理服务框架协议，12月18日股价上涨0.31%